风湿免疫科

订阅

MedSci主页 / 所有栏目 / 风湿免疫科

加拿大皮肤-风湿病学倡议小组的专家建议

2016-03-09 佚名 中华风湿病学杂志

皮肤-风湿病银屑病RA
关注

近几年，随着对炎性疾病发病机制及临床特征的深入了解，人们越来越关注炎性疾病伴随疾病的治疗及其在预后中的作用，多学科合作共同诊治炎性疾病多系统并发症已成为当今热点：2015年7月加拿大皮肤一风湿病学倡议小组在J Rheumatol上发表了一篇关于RA、银屑病(psoriasis)和PsA伴随疾病的管理建议。 该项工作共纳入1960-2012年Medline、EMbase、Cochrane图书馆三大

近几年，随着对炎性疾病发病机制及临床特征的深入了解，人们越来越关注炎性疾病伴随疾病的治疗及其在预后中的作用，多学科合作共同诊治炎性疾病多系统并发症已成为当今热点：2015年7月加拿大皮肤一风湿病学倡议小组在J Rheumatol上发表了一篇关于RA、银屑病(psoriasis)和PsA伴随疾病的管理建议。

该项工作共纳入1960-2012年Medline、EMbase、Cochrane图书馆三大数据库中的相关文献及2010-2012年风湿病和皮肤病主要学术会议的相关摘要共17575篇，并进行了包括风湿病学家、皮肤病学家、实习生、研究员及受邀专家在内的会议讨论，形成这一广泛认可的推荐意见。现将该意见整理如下(见表1)，与广大读者共同学习。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076973, encodeId=746920e6973f5, content=<a href='/topic/show?id=401ae198489' target=_blank style='color:#2F92EE;'>#皮肤-风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71984, encryptionId=401ae198489, topicName=皮肤-风湿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab72500038, createdName=124985dbm06(暂无昵称), createdTime=Sat May 21 18:10:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69196, encodeId=60c36919659, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Mon Mar 14 11:33:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312529, encodeId=c063131252975, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Fri Mar 11 03:10:00 CST 2016, time=2016-03-11, status=1, ipAttribution=)]
    2016-05-21 124985dbm06(暂无昵称)

    #皮肤-风湿病#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2076973, encodeId=746920e6973f5, content=<a href='/topic/show?id=401ae198489' target=_blank style='color:#2F92EE;'>#皮肤-风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71984, encryptionId=401ae198489, topicName=皮肤-风湿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab72500038, createdName=124985dbm06(暂无昵称), createdTime=Sat May 21 18:10:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69196, encodeId=60c36919659, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Mon Mar 14 11:33:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312529, encodeId=c063131252975, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Fri Mar 11 03:10:00 CST 2016, time=2016-03-11, status=1, ipAttribution=)]
    2016-03-14 三毛坨

    哈哈

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2076973, encodeId=746920e6973f5, content=<a href='/topic/show?id=401ae198489' target=_blank style='color:#2F92EE;'>#皮肤-风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71984, encryptionId=401ae198489, topicName=皮肤-风湿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab72500038, createdName=124985dbm06(暂无昵称), createdTime=Sat May 21 18:10:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69196, encodeId=60c36919659, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Mon Mar 14 11:33:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312529, encodeId=c063131252975, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Fri Mar 11 03:10:00 CST 2016, time=2016-03-11, status=1, ipAttribution=)]
    2016-03-11 shanyongle

    #加拿大#

    0